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Anti-adaptors use distinct modes of
binding to inhibit the
RssB-dependent turnover of RpoS
( Sσ ) by ClpXP
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Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia
In Escherichia coli, Sσ is the master regulator of the general stress response. The level
of Sσ changes in response to multiple stress conditions and it is regulated at many
levels including protein turnover. In the absence of stress, Sσ is rapidly degraded by the
AAA+ protease, ClpXP in a regulated manner that depends on the adaptor protein RssB.
This two-component response regulator mediates the recognition of Sσ and its delivery to
ClpXP. The turnover of Sσ however, can be inhibited in a stress specific manner, by one of
three anti-adaptor proteins. Each anti-adaptor binds to RssB and inhibits its activity, but
how this is achieved is not fully understood at a molecular level. Here, we describe details
of the interaction between each anti-adaptor and RssB that leads to the stabilization
of Sσ . By defining the domains of RssB using partial proteolysis we demonstrate that
each anti-adaptor uses a distinct mode of binding to inhibit RssB activity. IraD docks
specifically to the N-terminal domain of RssB, IraP interacts primarily with the C-terminal
domain, while IraM interacts with both domains. Despite these differences in binding, we
propose that docking of each anti-adaptor induces a conformational change in RssB,
which resembles the inactive dimer of RssB. This dimer-like state of RssB not only
prevents substrate binding but also triggers substrate release from a pre-bound complex.
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Introduction
In their natural environment, bacteria are constantly exposed to changing and sometimes
harsh environmental conditions. To survive these changes they have developed sophisticated
stress response pathways to regulate the expression of specific genes that either restore cellular
homeostasis or enable the bacteria to adapt to their new conditions. A key transcription fac-
tor or master regulator generally orchestrates these programmed changes. In Escherichia coli
and related enteric bacteria, the cells response to a wide variety of different stress conditions
(often referred to as the general stress response) is coordinated by a single transcription fac-
tor, σS (also known as σ38 or RpoS) (Hengge-Aronis, 2002). As such, the cellular levels of σS
are highly regulated, not only at the transcriptional and translational levels, but also at the post-
translational level through regulated proteolysis (Hengge, 2009; Battesti et al., 2011; Micevski
and Dougan, 2013). In the absence of stress, σS levels remain low, largely as a result of its
rapid turnover by the AAA+ (ATPases associated with a variety of cellular activities) protease
ClpXP. Importantly, the turnover of σS is mediated by a specialized adaptor protein, RssB
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(also known as SprE) (Muﬄer et al., 1996; Pratt and Silhavy,
1996). RssB is a member of the response regulator (RR) family
of proteins and like most RRs it is composed of two domains; a
receiver domain and an effector (or output) domain (Galperin,
2010). However, in the case of RssB these domains have yet to be
biochemically defined. As with most RRs the receiver domain of
RssB is proposed to act as a phosphorylation-mediated switch,
which regulates the activity of the effector domain (Gao and
Stock, 2010). Consistent with this idea, RssB can be phosphory-
lated on a highly conserved Asp residue (Asp58). To date how-
ever, the physiological role of RssB-phosphorylation as a means
to regulate σS levels remains controversial, as σS is only par-
tially stabilized in cells carrying a non-phosphorylatable mutant
of RssB (Peterson et al., 2004; Zhou and Gottesman, 2006). It has
recently been proposed that cellular ATP levels directly control σS
stability (Peterson et al., 2012). Independent of this control, both
the recognition of σS (by RssB) and its degradation (by ClpXP)
in vitro can be enhanced by phosphorylation of RssB. However,
the mechanistic details by which RssB binds to σS and delivers
it to ClpXP remains poorly understood (Hengge, 2009; Micevski
and Dougan, 2013).
The stability of σS is also regulated by a group of unre-
lated proteins, which collectively have been termed anti-adaptors
as they inhibit the activity of the adaptor protein RssB. Cur-
rently, three anti-adaptors have been identified in E. coli, all of
which inhibit the turnover of σS in response to a specific stress
(Bougdour et al., 2006, 2008). Related anti-adaptor proteins
have also been identified in Salmonella, however despite their
sequence similarity with E. coli anti-adaptors, these proteins are
regulated by different stress conditions (Bougdour et al., 2008;
Merrikh et al., 2009a,b). In E. coli the different anti-adaptors have
been named, IraP (Inhibitor of RssB activity during phosphate
starvation) which as the name suggests is specifically induced
in response to phosphate starvation, IraD which is specifically
induced in response to DNA damage and IraM which is specif-
ically induced in response to magnesium starvation.
Although the transcriptional regulation of all three anti-
adaptors has been extensively studied and is currently well under-
stood (Bougdour et al., 2006, 2008; Bougdour and Gottesman,
2007; Merrikh et al., 2009a,b; Battesti et al., 2012), the mechanism
of action of these proteins remains poorly defined. Here we show
via a detailed biochemical analysis, that all three anti-adaptors use
distinct modes of binding to inhibit RssB activity.
Results
RssB is Composed of Two Domains
To dissect the mode of action of the three known anti-
adaptor proteins, we first experimentally determined the domain
boundaries of RssB. To do so, we performed limited prote-
olysis on untagged RssB (Figure 1). In the presence of ther-
molysin, untagged RssB (∼36 kDa) was rapidly and specifically
cleaved into two fragments (Figure 1A). N-terminal sequenc-
ing of the larger (∼24 kDa) fragment (RVEEEE, corresponding
to residues 131–136 of RssB) revealed this fragment to be the
C-terminal effector domain. Therefore, in this study we defined
the C-terminal domain of RssB (RssBC) as residues 131–337 and
FIGURE 1 | RssB is composed of two domains. (A) In the presence of
thermolysin, RssB was digested into two stable fragments (RssBN and
RssBC). Proteins were separated by SDS-PAGE and stained with CBB. (B)
Schematic diagram of recombinant RssBN (residues 1–129) and RssBC,
(residues 131–337) used in this study.
the N-terminal domain (RssBN) as residues 1–129 (Figure 1B).
Next, untagged versions of each domain (RssBN and RssBC) were
purified (Figure S1A) using the ubiquitin (Ub) fusion system
(Catanzariti et al., 2004). To assess the activity of these domains,
a series of competition-based degradation experiments were per-
formed, in which the RssB-mediated turnover of σS by ClpXP
was monitored either in the absence or presence of RssBN or
RssBC (Figure S1B). Importantly, neither RssBN (Figure S1B,
lower panel) nor RssBC (Figure S1B, middle panel) altered the
RssB-mediated turnover of σS (Figure S1B, upper panel). These
findings validated the use of these domains to assess their ability
to bind to and hence inhibit the activity of each anti-adaptor in
competition assays.
IraD Binds to the N-Terminal Response Regulator
Domain of RssB
First we asked the question, does IraD interact with an individ-
ual domain of RssB? To address this question we monitored the
ability of IraD to inhibit the RssB-mediated turnover of σS, either
in the absence of added domains [Figure 2A, (ii) and B, open cir-
cles] or in the presence of RssBN [Figure 2A, (vi) and B, open
triangles] or RssBC [Figure 2A, (iv) and B, open diamonds]. As
expected IraD was able to inhibit the RssB-mediated turnover of
σS, however in the presence of RssBN, the IraD-mediated inhi-
bition of σS turnover was completely reversed. Importantly, this
effect was specific for RssBN, as addition of RssBC was unable to
relieve IraD-mediated inhibition. These data indicate that only
RssBN can compete with full length RssB for binding to IraD and
suggest that IraD binds specifically to the N-domain of RssB. To
confirm if this relief of IraD inhibition on σS degradation was
due to a specific interaction between IraD and the N-domain
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FIGURE 2 | IraD specifically interacts with the N-terminal domain of
RssB. (A) The RssB-mediated turnover of σS by ClpXP, was monitored in
the absence of added domains (i and ii), or in the presence of either RssBC
(iii and iv) or RssBN (v and vi), with (ii, iv, and vi) or without (i, iii, and v) IraD.
Strips show σS following separation by SDS-PAGE and staining with CBB.
(B) The RssB-mediated turnover of σS by ClpXP (control) was monitored
either in the presence of RssBC (diamonds) or RssBN (triangles), with (open
symbols) or without (filled symbols) IraD as shown in (A). Quantification (using
GelEval) of the relative amount of σS remaining, from three independent
experiments (n = 3). Error bars represent the standard error of the mean
(s.e.m.). (C) Ni-NTA agarose beads either lacking or containing immobilized
IraD were incubated with either RssB, RssBN or RssBC (lanes 2–8) and
following washing the bound proteins were eluted with imidazole (lanes
9–15). Proteins were separated by SDS-PAGE and visualized with CBB. (D)
CBB-stained strips, from multiple SDS-PAGE gels showing fractions
following separation of 5 nmol of either IraD (top panel), RssBN (middle panel)
or the IraD-RssBN complex (lower panel), by SEC using Superdex 75. (E)
The RssB-mediated turnover of σS by ClpXP (control) was monitored either
in the absence (open circles) or presence (filled circles) of IraD. The
IraD-inhibited turnover of σS was monitored in the presence of wild type
(open squares), L36D (open diamonds) or L106D (open triangles) RssBN
(labeled RssBN, NL36D and NL106D, respectively). Quantification (using
GelEval) of the relative amount of σS remaining, from three independent
experiments (n = 3). Error bars represent the s.e.m. (F) Following
preincubation of σS with RssB (+AcP), IraD was added to the reaction prior
to separation of the proteins using Superdex 200. Following separation of the
proteins by SEC, the fractions were analyzed by SDS-PAGE and the amount
of σS quantified using GelEval. The elution profile of σS (open circles) is
shifted in the presence of RssB (open diamonds). The addition of IraD to a
pre-formed RssB/σS complex prevents this shift of σS (filled triangles).
of RssB, a series of pull-down experiments were performed. In
these experiments purified His10-tagged IraD was immobilized
to Ni-NTA agarose beads and assessed for its ability to bind
purified recombinant untagged RssB domains. As expected full-
length RssB was specifically eluted from Ni-NTA beads contain-
ing immobilized IraD (Figure 2C, lane 11) and not from beads
lacking immobilized protein (Figure 2C, lane 9). Importantly,
only RssBN was specifically eluted from beads containing immo-
bilized IraD (Figure 2C, lane 13) confirming that the N-terminal
domain of RssB is sufficient for interaction with IraD.
To validate this mode of binding and estimate the stoichiom-
etry of the complex we performed size exclusion chromatogra-
phy (SEC). In the absence of RssBN, IraD eluted in two peaks
(Figure 2D, upper panel); the predominant peak (∼15ml) rep-
resenting a monomer of IraD, and a minor peak (∼14ml) repre-
senting the IraD dimer. Similarly, in the absence of IraD, RssBN
also eluted in two peaks (Figure 2D, middle panel) a monomer
at ∼14ml, and a minor dimeric peak (at ∼13ml). Importantly,
when both proteins were incubated together and analyzed by
SEC, both IraD and RssBN (Figure 2D, lower panel) co-eluted,
in a single peak at ∼12ml. Based on the molecular weight of
this peak (estimated using protein standards) and the intensity
of the two protein bands we propose that IraD and RssBN form
a heterodimer. Interestingly, a shift in the homodimer of RssBN
(albeit a minor component) was not observed, suggesting that
this form of RssBN is unable to interact with IraD (Figure 2D).
To investigate a possible role of the RssBN dimerization inter-
face in IraD binding, we generated a mutant of RssBN lacking the
β5-α5 segment referred to here as RssBN1−104. Based on the struc-
ture of Pseudomonas aeruginosa RssB (PDB: 3EQ2; Levchenko
et al., unpublished) this segment of RssB forms the dimeriza-
tion interface. Analysis by SEC (data not shown) revealed that
the elution profile of RssBN1−104 was not altered in the presence
of IraD consistent with a loss of interaction. Collectively these
data suggest that IraD binds to RssB through its dimerization
interface. Importantly, the dimer of RssB is unable to recog-
nize or deliver σS to ClpXP for degradation (Figure S2). Hence,
we propose that IraD-binding, to the dimerization interface,
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triggers a switch in the conformation of RssB, which mimics the
domain arrangement present in the dimeric form. We refer to
this conformation as the “off ” state.
To further validate this interaction site, we generated two sin-
gle point mutations in RssBN, which based on its similarity to
other RRs are located on opposite faces of the protein. In each
case, a central hydrophobic residue (L36 within the N-terminal
1-2-2 interface or L106 within the C-terminal 4-5-5 interface) was
replaced with aspartate (Figure S3). Tomonitor the effect of these
single point mutations on the interaction with IraD we compared
the ability of wild type and mutant N-domains (referred to here
as NL36D and NL106D, respectively) to relieve the IraD-mediated
inhibition of σS degradation (Figure 2E). This analysis revealed
that NL106D exhibited a reduced ability to relieve the IraD-
mediated inhibition of σS degradation in comparison to wild type
RssBN (Figure 2E, compare open triangles with open squares).
In contrast, NL36D retained the ability to inhibit IraD-activity
(Figure 2E, open diamonds). Hence, these data confirm that IraD
binds to N-terminal domain of RssB through the dimerization
interface, which is directly linked to the C-terminal domain.
Consequently, we propose that IraD-binding to the N-terminal
domain may modulate communication to the C-terminal effec-
tor domain of RssB, where σS docking occurs (manuscript in
preparation).
Next to determine if IraD was able to trigger release of σS
from RssB we monitored the elution profile of the RssB/σS com-
plex by SEC, before and after the addition of IraD (Figure 2F).
In the absence of IraD, σS co-eluted with RssB in a single
peak at ∼10ml (Figure 2F, open diamonds). However, follow-
ing the addition of IraD to a preformed RssB/σS complex, the
elution profile of σS (Figure 2F, filled triangles) resembled that
of σS alone (Figure 2F, open circles). These data suggest that
binding of IraD to the dimerization interface of RssB stabilizes
the adaptor protein in a dimer-like conformation that triggers
release of σS.
IraP Binds to the C-Terminal Effector Domain of
RssB
Next, we asked the question, does IraP use a similar or distinct
mechanism to inhibit the RssB-mediated degradation of σS? To
address this question we monitored the ability of IraP to inhibit
the RssB-mediated turnover of σS, in the absence or presence
of a 2.5-fold excess of either RssBN or RssBC (Figures 3A, B).
Consistent with published data (Bougdour et al., 2006, 2008),
recombinant IraP was able to inhibit the RssB-mediated degra-
dation of σS by ClpXP [Figure 3A, compare (ii) with (i)], how-
ever in comparison to IraD, IraP was a less potent inhibitor of
σS degradation (compare Figures 2B, 3B). Interestingly, in con-
trast to the analysis of IraD (Figure 2B, compare open diamonds
with open circles) the addition of RssBC was sufficient to par-
tially inhibit IraP-activity as seen by the loss of inhibition of σS
turnover (Figure 3B, compare open diamonds with open circles),
while RssBN had no effect on the turnover of σ
S (Figure 3B,
compare open triangles with open circles). To examine more
directly the mode of interaction between IraP and RssB, we mon-
itored the binding of IraP with each RssB domain, using a series
of pull-down experiments, in which purified recombinant IraP
was immobilized to Ni-NTA agarose beads, via a C-terminal
His10-tag (Figure 3C). Consistent with the competition degra-
dation assays (Figures 3A, B), an interaction between RssBC and
immobilized IraP was observed (Figure 3C, lane 14). Although
a specific interaction between RssBN and IraP was not detected
in most pull-down experiments as shown in the representative
example (Figure 3C, lane 12) “weak” binding was observed in
a single experiment. Collectively, these data clearly indicate that
IraP docks onto the C-terminal effector domain of RssB however
a potential role, for the N-terminal domain could not be com-
pletely excluded. To further examine any possible contribution
of the N-terminal domain of RssB in binding to IraP, we again
employed the competition-based degradation assay to monitor
σS turnover. In this case, the turnover of σS was monitored in the
presence of increasing concentrations of RssBN (up to a 20-fold
excess), either in the absence or presence of IraP (Figure 3D).
Consistent with a weak interaction between IraP and RssBN the
rate of σS turnover (in the presence of IraP) increased in the
presence of higher concentrations of RssBN (Figure 3D, columns
7–10), while the same concentrations of RssBN did not affect the
rate of σS turnover in the absence of IraP (Figure 3D, columns
3–6). Collectively these data suggest that in contrast to IraD, IraP
interacts with both domains of RssB. However, based on the rel-
ative ability of each domain to inhibit IraP activity, IraP appears
to bind with higher affinity to the C-terminal domain of RssB.
Given the apparently weak interaction of IraP with the
N-terminal domain, we chose to further clarify this interac-
tion by examining the role of phosphorylation (of Asp58)
on IraP-binding. In this case, we initially generated a non-
phosphorylatable mutant of RssBN in which Asp58 was replaced
with Lys (here referred to as ND58K) and compared the abil-
ity of this mutant (relative to wild type RssBN) to inhibit IraP
binding to full-length RssB in the presence of the phospho-
donor, AcP (Figure 3E, S4). Importantly, given that this mutant
cannot be phosphorylated, this permitted a direct comparison
of RssBN phosphorylation and IraP binding in the presence of
AcP. Consistent with our previous findings (Figure 3D), a 5-fold
excess of RssBN resulted in a ∼2-fold increase in the rate of
σS turnover in the presence of IraP (Figure S4). In contrast, a
5-fold excess of ND58K did not alter the IraP-mediated inhibi-
tion (Figure 3E, S4). Next we performed a series of pull-down
experiments to directly monitor the interaction between IraP and
RssB (Figure 3F). In this case, we replaced Asp58 with either Pro
or Ala to generate two well-characterized non-phosphorylatable
mutants of RssB, RssB(D58P) or RssB(D58A) (Bouche et al.,
1998; Peterson et al., 2004), here referred to as D58P and D58A,
respectively. Specifically, wild type or mutant RssB was expressed
in presence or absence of His6-tagged IraP, the cell lysate was
then applied to Ni-NTA beads and after extensive washing to
remove non-specifically bound proteins, IraP was eluted with
imidazole and the relative amount of RssB (wild type or mutant)
specifically co-eluting with IraP determined. Consistent with the
in vitro pull-down (shown in Figure 3C) a small amount of
RssB was found to interact non-specifically with the beads how-
ever the levels of RssB recovered were significantly increased in
the presence of IraP (Figure 3F, compare black bars). Impor-
tantly, mutation of Asp58 (to either Pro or Ala) resulted in a
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FIGURE 3 | Interaction of IraP with RssB. (A,B) The RssB-mediated
turnover of σS by ClpXP (control), was monitored in the absence of added
domains (i and ii), or in the presence of either RssBC (iii and iv) or RssBN (v
and vi), with (ii, iv, and vi) or without (i, iii, and v) IraP. Proteins were separated
by SDS-PAGE and stained with CBB. Only the σS-strip of the gel is shown.
(B) The amount of σS remaining was quantified from three independent
experiments. Error bars represent s.e.m. (C) Ni-NTA agarose beads either
lacking or containing immobilized IraP were incubated with RssB, RssBN, or
RssBC (lanes 1–7) and following washing the bound proteins were eluted
with imidazole (lanes 8–14). Proteins were detected by immunoblotting (as
indicated) following separation by SDS-PAGE. (D) The initial rate of σS
degradation in the absence of IraP (lane 1) was compared to the rate of
degradation in the presence of IraP (lane 2) or with increasing concentrations
(5, 10, 15, and 20µM) of RssBN either in the absence (lanes 3–6) or presence
(lanes 7–10) of IraP. n = 3, and error bars represent the s.e.m. (E) The
RssB-mediated turnover of σS by ClpXP, was monitored either in the absence
of added domains (i and ii), or in the presence of wild type RssBN (iii and iv) or
ND58K (v and vi), with (ii, iv, and vi) or without (i, iii, and v) IraP and separated
by 15% SDS-PAGE. (F) The interaction of His6-IraP with wild type or mutant
RssB was monitored by pull-down. Recovery of wild type RssB (black bar),
D58P (white bar) or D58A (gray bar) was determined from the quantitation of
three independent experiments. Error bars represent the s.e.m.
dramatic loss in the amount of RssB bound to IraP (Figure 3F,
white or gray bars, respectively). Collectively, these data sug-
gest that IraP docks to the C-terminal domain of RssB, how-
ever its binding appears be stabilized by the phosphorylation
state of the N-terminal domain. Next, to confirm if the stabi-
lized binding of IraP to RssBC was driven by a conformational
change in the C-terminal domain of RssB induced by phospho-
rylation of the N-domain we examined if binding of RssBC (or
indeed RssBN) could be enhanced in trans (Figure S5). To do
so, we monitored the binding of IraP to each RssB domain,
either alone or together (Figure S5). Consistent with the idea
that phosphorylation of the receiver domain drives a conforma-
tional change in the effector domain, which triggers improved
interaction with IraP, the addition of RssBN in trans did not
enhance the recovery of RssBC. In contrast, the recovery of
RssBN was reduced in the presence of RssBC, confirming that
the N-domain alone interacts only weakly with IraP (Figure S5,
lane 5).
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FIGURE 4 | Interaction of IraM and RssB. (A) Following incubation of
Ni-NTA agarose beads with lysates either lacking (lanes 2, 4, and 6) or
containing (lanes 1, 3, 5, and 7) overexpressed His6-IraM, in the presence of
recombinant RssB (lanes 2 and 3), RssBN (lanes 4 and 5) or RssBC (lanes 6
and 7) the beads were washed extensively then IraM, together with
interacting proteins were eluted with imidazole. Proteins were detected by
immunoblotting (as indicated) following separation by 16.5% Tris-Tricine
SDS-PAGE. (B) The recovery of RssBN (white bar) or RssBC (gray bar)
relative to RssB (black bar) was determined from the quantitation of three
independent experiments. Error bars represent the s.e.m.
IraM Binds to Both Domains of RssB
To determine if the third anti-adaptor, IraM,mimicked the action
of IraD or IraP, its ability to bind to the domains of RssB was
examined. In this case, due to poor recovery of recombinant
IraM, we chose to monitor the binding of IraM to the differ-
ent domains of RssB via pull-down experiments using cell lysates
in which the proteins of interest were co-expressed. Specifically,
we generated a series of clones, which enabled the overexpres-
sion of untagged RssB (full-length or individual domains) in
the absence or presence of overexpressed His6-IraM. Following
preliminary evaluation of the levels of soluble IraM and RssB
(within the cell lysate) via SDS-PAGE (Figure S6) the appropri-
ate amount of each lysate was applied to Ni-NTA agarose beads
and the pull-down performed. The eluted proteins were evalu-
ated by immunoblotting (Figure 4A) using the appropriate anti-
body. As expected, full-length RssB was specifically recovered,
from the column containing immobilized His6-IraM (Figure 4A,
lane 3). Interestingly, in contrast to both IraD and IraP, IraM
appeared to form a stable interaction with both domains of RssB
(Figure 4A). Indeed, based on the recovery of each domain in
comparison to the input, both domains appear to contribute
equally to IraM binding (Figure 4B). These data indicate that
IraM imposes its inhibitory effect on RssB activity through dock-
ing to both domains of RssB. Although this mode of binding is
similar to that of IraP, the relative contribution of each domain
appears to be quite different. Next, we examined if both domains
can function in trans. To do so we compared the binding of each
domain to IraM, either alone or in the presence of the other
domain (Figure S7). Unexpectedly, and in contrast to IraP (Fig-
ure S5), we observed an improved recovery of RssBN (when incu-
bated in the presence of RssBC). These data suggest that the C-
terminal domain of RssB can promote binding of RssBN to IraM,
by stabilizing RssBN (or IraM) in a conformation that is permis-
sive for interaction with the other component. Collectively, these
data suggest that all three anti-adaptors use distinct modes of
binding to inhibit RssB-activity.
Anti-Adaptor Binding Triggers a Conformational
Change in RssB
While each anti-adaptor exhibited a different mode of binding to
RssB it still remained to be determined how they inhibit the RssB-
mediated recognition of σS. One possibility is that each anti-
adaptor simply inhibits substrate engagement by RssB via steric
hindrance due to the presence of the bound anti-adaptor. This
however, at least in the case of IraD, appears unlikely as the anti-
adaptor binds specifically to RssBN and this binding is sufficient
to trigger release of σS from the C-domain of RssB, in a preformed
RssB/σS complex. An alternative possibility is that anti-adaptor
binding triggers a conformational change in RssB that promotes
release of σS from a second site. To gain further insight into the
mode of action of the RssB anti-adaptors we repeated the partial
proteolysis experiments, in the absence or presence of either IraD
(Figure 5A) or IraP (Figure 5C). Consistent with our previous
data (Figure 1A), in the absence of anti-adaptor, RssB was rapidly
cleaved into two stable domains upon addition of thermolysin
(Figure 5A, top panel). In contrast to RssB, IraD was rapidly
and completely degraded following the addition of thermolysin
(Figure 5A, middle panel). However, when IraD was incubated
with RssB, both proteins were clearly protected from cleavage by
thermolysin (Figure 5A, lower panel). In the case of RssB, the
entire protein was completely stable while in the case of IraD only
a fragment of the protein (here termed IraDcore) remained sta-
ble throughout the experiment. To determine if stabilization of
the IraDcore fragment was solely due to its interaction with the
N-terminal domain of RssB, we repeated the IraD partial prote-
olysis experiment in the presence of RssBN (Figure 5B). These
data clearly show, that RssBN is not only sufficient to stabilize
the core fragment of IraD, but also verifies that IraDcore migrates
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FIGURE 5 | IraD and IraP trigger a conformational change in RssB. (A)
The domain structure of RssB was analyzed by partial proteolysis using
thermolysin in the absence (top panel) or presence (lower panel) of IraD. As a
control IraD (alone) was also analyzed in the presence of thermolysin (middle
panel). (B) The core domain of IraD (IraDcore) is stabilized by RssBN (from
partial proteolysis with thermolysin). (C) The domain structure of RssB was
monitored in the presence of IraP, using thermolysin. (A–C) Proteins were
separated by SDS-PAGE and stained with CBB. (D) SigmaS (σS) is unable to
protect the RssB linker region from cleavage by thermolysin. The domain
structure of RssB was analyzed by partial proteolysis with thermolysin in the
absence (top panel) or presence (bottom panel) of σS. Following partial
proteolysis in the presence of thermolysin (lanes 2–6), the protein fragments
were separated by SDS-PAGE, transferred to PVDF membrane and
immunodecorated with α-RssB antisera, to specifically detect the RssB
fragments.
with a different mobility to RssBN. Collectively these data suggest
that binding of IraD to the N-terminal domain of RssB is suffi-
cient to trigger a conformational change in RssB, which protects
it from cleavage by thermolysin. Next we examined whether IraP
also protected RssB in the limited proteolysis assay, in the same
manner as IraD. Consistent with the effect of IraD, IraP also stabi-
lized full-length RssB, however in contrast to IraD, a concomitant
stabilization of the anti-adaptor was not observed (Figure 5C).
These data suggest that only a short fragment of IraP is required
for binding to RssB, and that this fragment is sufficient to sta-
bilize the protease-protected or inactive conformation of RssB.
Importantly, in contrast to both IraD and IraP, σS did not pro-
tect RssB from cleavage by thermolysin (Figure 5D). These data
suggest that in comparison to anti-adaptor docking, substrate
binding to RssB either occurs through a different site on RssB or
alternatively does not trigger the same conformational change.
Discussion
RpoS is the central regulator of the general stress response in
E. coli. In the absence of stress, the cellular levels of σS are
undetectable (< 1 molecule/cell), however in the presence of
stress the level of σS increases rapidly, up to∼ 230 molecules/cell
during stationary phase (Jishage and Ishihama, 1995; Maeda
et al., 2000). This rapid change in cellular concentration of σS is
largely achieved by regulating its turnover. Under normal condi-
tions σS is rapidly degraded by the AAA+ protease ClpXP, which
is mediated by a specialized adaptor protein RssB. However, upon
exposure to stress the RssB-mediated turnover of σS is inhibited
by one of three stress-specific anti-adaptor proteins IraD, IraP
or IraM. Although the molecular components of this regulated
protein degradation pathway have been reconstituted in vitro,
currently little progress has been made toward determining the
molecular basis of inhibition by these anti-adaptors.
Here, we have experimentally determined the domain struc-
ture of RssB (Figure 1) and defined the first mechanistic details
of each anti-adaptor. Interestingly, each anti-adaptor interacts
with RssB in a specific manner. Consistent with recent data
from Gottesman and colleagues (Battesti et al., 2013) we found
that IraD docks exclusively to the N-terminal domain (Figure 2)
and IraM interacts with both domains (Figure 4). However, in
contrast to Gottesman and colleagues (Battesti et al., 2013), we
find that IraP interacts primarily with the C-terminal domain
(Figure 3) although the interaction appears to be modulated by
phosphorylation of the N-domain of RssB. Importantly, our data
suggests that anti-adaptor docking, to either domain, triggers a
conformation change in RssB (Figure 5), which results in sub-
strate release. Specifically, we propose that IraD binding, to the
dimerization interface of RssB, stabilizes an inactive conforma-
tion of RssB, which triggers release of σS from the C-terminal
effector domain. Consistent with this model, binding of IraP to
the C-terminal domain of RssB appears to induce a similar con-
formational change and hence we speculate that all three anti-
adaptors, independent of their mode of docking to RssB, induce a
conformational change in RssB, that mimics the inactive dimer-
like state of RssB, which is unable to bind (or deliver) σS (this
model is summarized in Figure 6).
In the case of IraP, a short region of this anti-adaptor appears
to be sufficient to stabilize the inactive conformation of RssB.
Consistent with this idea, a short region (hexapeptide) of the
Bacillus subtilis anti-adaptor–ComS, is sufficient to displace the
substrate ComK from the adaptor protein MecA, and hence
inhibit its degradation by the ClpCP protease (Turgay et al.,
1998; Prepiak and Dubnau, 2007). In this case however, the anti-
adaptor appears to compete directly with the substrate for bind-
ing to the same site on MecA and as a result ComS is also
degraded by the ClpCP/MecA protease. In contrast to MecA,
we propose that RssB interacts with the anti-adaptors (IraD and
IraP) and the substrate (σS) through distinct binding sites, as
degradation of the RssB-anti-adaptors by their cognate protease
has not been observed.
Based on bioinformatic analysis of the IraP amino acid
sequence, the short region of IraP responsible for interaction with
RssB could be located within the N-terminus of the anti-adaptor,
as this region is predicted to form a coiled-coil (residues 1–35).
Similarly a short segment (residues 127–155) in the C-terminal
domain of RssB is also predicted to form a coiled-coil. Given that
coiled-coils often play important roles in biological interactions,
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FIGURE 6 | Cartoon illustrating a model of the different modes of
action of the three anti-adaptors, IraD (green), IraP (pink), and IraM
(yellow). In the absence of anti-adaptors, RssB (blue) is able to recognize
the transcription factor σS (gray). This recognition is inhibited by dimerization
of RssB and enhanced by phosphorylation of the N-terminal domain of
RssB. Anti-adaptor binding not only inhibits the recognition of σS, but in the
case of IraD, also triggers the release of σS. Binding of IraD (to RssBN) and
IraP (to RssBC) triggers a conformational change in RssB, which we propose
resembles the dimer-like state or RssB. Binding of IraM to both domains
inhibits σS interaction via an unknown mechanism.
one possibility is that both coiled-coils drive the formation of the
heterodimeric complex. This interaction could result in a con-
formational change to RssB, or alternatively it could stabilize a
conformation of RssB, which prevents substrate binding. Consis-
tent with this idea, a single point mutant (L9S) within the coiled-
coil region of IraP reduces its inhibitory activity (Bougdour et al.,
2006). Interestingly, the structure of full-length RssB from P.
aeruginosa (3EQ2) also contains a coiled-coil region, located
between the N- and C-terminal domains, which appears to medi-
ate homodimer formation. Based on our biochemical data, the
dimeric conformation of E. coli RssB is unable to deliver σS to
ClpXP for degradation. Therefore, we propose that IraP, similar
to IraD, stabilizes RssB in a dimer-like conformation, which ren-
ders RssB unable to recognize or deliver σS to ClpXP for degra-
dation. This mode of inhibition shares some striking similarities
to the regulation of a quorum sensing transcriptional activator
(TraR) in bacteria such as Agrobacterium tumefaciens, which is
controlled through its interaction with a quorum sensing anti-
activator, known as TraM. Similar to IraP, TraM also contains
a coiled-coil region, which is involved not only in homodimer
formation (Chen et al., 2004), but also in binding to TraR result-
ing in the formation of the TraR-TraM anti-activation complex
(Chen et al., 2007). In this case, TraM binding to one site in TraR,
has been shown to cause a conformational change in TraR that
prevents substrate binding at a second site.
Collectively, our data shows that each anti-adaptor forms
a stable complex with RssB, albeit through a unique mode
of binding. Atomic resolution structures of each anti-adaptor,
both alone and in complex with the adaptor protein RssB,
are eagerly awaited to better understand the nature of these
interactions.
Experimental Procedures
Protein Purification and Size Exclusion
Chromatography
His6-tagged ClpX and ClpP were overexpressed in E. coli and
purified as described previously (Dougan et al., 2003). His10-
tagged IraP and IraD were overexpressed in E. coli and purified
essentially as described by Bougdour et al. (2008). Untagged σS,
RssB, RssBC, and RssBN (wild type and specific point mutants)
were generated using the Ub-fusion system (Catanzariti et al.,
2004) and purified essentially as described previously (Ninnis
et al., 2009), using a combination of IMAC and preparative grade
SEC to separate monomeric and dimeric RssB. To examine the
different protein complexes, analytical SEC was performed. All
columns were pre-equilibrated in chilled GF buffer (20mM Tris-
HCl pH 7.5, 10mMMgCl2, 0.1mM EDTA, 1mM DTT, 140mM
NaCl, 5% (v/v) glycerol, 0.005% (v/v) Triton X-100).
In Vitro Degradation Assays
The in vitro σS degradation assays were performed essentially as
described (Zhou et al., 2001) with minor modifications. All reac-
tions were performed in degradation buffer (20mM Tris-HCl
pH 7.5, 140mM NaCl, 10mM MgCl2, 0.1mM EDTA, 5% (v/v)
glycerol, 0.005% (v/v) Triton X-100, 1mM DTT) and contained
1µM σS. Unless otherwise stated reactions containing σS were
pre-incubated at 30◦C, with 1µMClpX, 1µMClpP and 0.08µM
monomeric RssB and 20mM of the phospho donor, acetyl phos-
phate (AcP) (Bouche et al., 1998). Where indicated IraD (1µM),
IraP (1µM), RssBN (2.5–20µM), and RssBC (2.5µM) were
included. All reactions were initiated with the addition of 2mM
ATP and samples collected at the specified time-points. Samples
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were separated using SDS-PAGE and visualized using Coomassie
Brilliant Blue (CBB) staining.
Limited Proteolysis
Limited proteolysis experiments were performed using ther-
molysin as described previously (Lowth et al., 2012). Following
a short pre-incubation (2min at 25◦C) in the absence of the pro-
tease, the substrate (i.e., RssB with or without anti-adaptor) was
incubated with the protease. Reactions were stopped with the
addition of PMSF (6mM) and 1 × SDS-PAGE sample buffer.
Proteins were separated by SDS-PAGE and visualized by staining
with CBB.
In Vitro “Pull-Down” Experiments
To examine the interaction of RssB (either full-length protein or
individual domains) with purified IraD or IraP, in vitro “pull-
down” experiments were performed as previously described
(Geissler et al., 2002). To examine the interaction of IraM or IraP
with RssB (full-length protein (wild type or mutant) and indi-
vidual domains), “pull-down” experiments were performed using
soluble protein extracts isolated from BL21(DE3) codon+ cells in
which untagged RssB (full-length (wild type or mutant) or indi-
vidual domains) was overexpressed in the absence or presence
of either His6-IraM or His6-IraP. Following overexpression of
the proteins, a series of soluble lysates were prepared in extrac-
tion buffer (20mM Tris-HCl pH 7.9, 500mM NaCl, 10% (v/v)
glycerol, 10mM imidazole, 1% (v/v) Triton X-100). Based on
the amount of IraM present within each soluble lysate, between
40 and 160mg of total protein was applied to 100µl of pre-
equilibrated Ni-NTA agarose beads. To monitor the in trans
binding of each RssB domain to the immobilized anti-adaptor
proteins (IraP or IraM) the appropriate lysate was supplemented
with 250µg of RssBN. Soluble protein lysates (in the presence
or absence of additional RssBN) and Ni-NTA agarose beads
were then incubated for 30min at 4◦C. The beads were then
transferred to individual MoBiTec columns. Further washes and
recovery of bound proteins was performed as described (Geissler
et al., 2002).
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